Market revenue in 2024 | USD 46.0 million |
Market revenue in 2030 | USD 50.8 million |
Growth rate | 1.7% (CAGR from 2025 to 2030) |
Largest segment | Conventional |
Fastest growing segment | Molecular |
Historical data | 2018 - 2023 |
Base year | 2024 |
Forecast period | 2025 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Molecular, Conventional |
Key market players worldwide | BioMerieux SA, Abbott, F. Hoffmann-La Roche Ltd., Siemens Healthineers AG ADR, Becton Dickinson & Co, Qiagen NV, Thermo Fisher Scientific Inc, Meridian Bioscience, Hologic, Inc. |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to hospital acquired infections diagnostics market will help companies and investors design strategic landscapes.
Conventional was the largest segment with a revenue share of 54.13% in 2024. Horizon Databook has segmented the Kuwait hospital acquired infections diagnostics market based on molecular, conventional covering the revenue growth of each sub-segment from 2018 to 2030.
In Kuwait, the HAI diagnostics market features prominent global players such as Abbott Laboratories, Thermo Fisher Scientific, and Siemens Healthineers, alongside regional distributors who cater to the specific needs of the Kuwaiti healthcare sector.
These global firms dominate the market by offering advanced diagnostic technologies and leveraging long-standing relationships with key healthcare providers. Local distributors play a vital role in ensuring the availability of products and providing aftersales support.
Recent market activities include the introduction of automated diagnostic platforms and real-time PCRbased solutions aimed at enhancing diagnostic efficiency. Strategic collaborations between global players and Kuwaiti healthcare institutions are becoming more prevalent, focusing on knowledge transfer and capacity building.
Horizon Databook provides a detailed overview of country-level data and insights on the Kuwait hospital acquired infections diagnostics market , including forecasts for subscribers. This country databook contains high-level insights into Kuwait hospital acquired infections diagnostics market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account